#therapeutics
Global Alzheimer's Therapeutics Market Expands at 9.3% CAGR as Biologics and Early Diagnosis Transform Dementia Care
NEWARK, Del., May 20, 2026 /PRNewswire/ -- The global Alzheimer's Therapeutics Market is projected to grow from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, expanding at a CAGR of 9.3% during the forecast period. According to Future Market Insights (F…
Global Alzheimer's Therapeutics Market Expands at 9.3% CAGR as Biologics and Early Diagnosis Transform Dementia Care
NEWARK, Del., May 20, 2026 /PRNewswire/ -- The global Alzheimer's Therapeutics Market is projected to grow from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, expanding at a CAGR of 9.3% during the forecast period. According to Future Market Insights (F…
Methotrexate Drugs Strategic Business Research Report 2026: Market to Surpass $600 Million by 2032 - Spotlight as a Key Chemotherapeutic Agent, Increasing Prevalence of Autoimmune Diseases
The methotrexate drugs market is driven by rising autoimmune disease prevalence, technological advances in drug delivery, and increased availability of generics. Demand growth is fueled by the aging population and cost-effectiveness of methotrexate, while inn…
Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
The global colorectal cancer diagnostics and therapeutics market is witnessing steady growth due to the rising prevalence of colorectal cancer, increasing awareness about early screening, and advancements in precision medicine. Growing adoption of non-invasiv…
Fibromyalgia Market Competitive Landscape Report 2026: Market is Not Likely to See Any Major Shifts in the Near Term, with No Products in Pre-registration or Phase III Development.
The main market opportunities in fibromyalgia therapeutics include the significant number of anticipated cases in India by 2029, a limited treatment landscape with few approved drugs and generics dominance, and untapped potential in early-stage clinical asset…